ArticleInternational journal of hematology2022
Correction to: A phase II study of post‑transplant cyclophosphamide combined with tacrolimus for GVHD prophylaxis after HLA‑matched related/unrelated allogeneic hematopoietic stem cell transplantation.
Hirohisa Nakamae et al.PubMed ↗Publisher ↗
No numbers read from the abstract.